Stem cell therapy: Past, present, and future

Advances in Tissue Engineering

Volumn , Issue , 2008, Pages 561-591

  Baron, Frédéric ^a   Storb, Rainer ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allogeneic; Bone Marrow; Cord Blood; Dog; Duchenne Muscular Dystrophy; Graft versus Host Disease; Graft versus Tumor Effects; Hematopoietic Cell Transplatation; Hematopoietic Stem Cell; Mesenchymal Stem Cells; Peripheral Blood Mononuclear Cells; Plasticity; Transplantation

Indexed keywords

EID: 78649889055     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781848161832_0027     Document Type: Chapter

References (152)

1. Thomas, E.D. and Blume, K.G. Historical markers in the development of allogeneic hematopoietic cell transplantation (Review). Biol. Blood Marrow Transplant. 5, 341-346 (1999).
2. Little, M.-T. and Storb, R. History of haematopoietic stem-cell transplantation. Nat. Rev. Cancer 2, 231-238 (2002).
3. Santos, G.W. Historical background. In: Atkinson, K. (ed.), Clinical Bone Marrow Transplantation: A Reference Textbook (Cambridge University Press, Cambridge, UK, 1994), pp, 1-9.
4. Jacobson, L.O., Marks, E.K., Robson, M.J., Gaston, E.O. and Zirkle, R.E. Effect of spleen protection on mortality following X-irradiation. J. Lab. Clin. Med. 34, 1538-1543 (1949).
5. Jacobson, L.O., Simmons, E.L., Marks, E.K. and Eldredge, J.H. Recovery from radiation injury. Science 113, 510-511 (1951).
6. Lorenz, E., Uphoff, D., Reid, T.R. and Shelton, E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J. Natl. Cancer Inst. 12, 197-201 (1951).
7. van Bekkum, D.W. and de Vries, M.J. Radiation Chimaeras (Logos Press Limited, London, 1967).
8. Nowell, P.C., Cole, L.J., Habermeyer, J.G. and Roan, P.L. Growth and continued function of rat marrow cells in X-radiated mice. Cancer Res. 16, 258-261 (1956).
9. Lindsley, D.L., Odell, T.T. and Tausche, F.G. Implantation of functional erythropoietic elements following total-body irradiation. Proc. Soc. Exp. Biol. Med. 90, 512-515 (1955).
10. Ford, C.E., Hamerton, J.L., Barnes, D.W.H. and Loutit, J.F. Cytological identification of radiation-chimaeras. Nature 177, 452-454 (1956).
11. Becker, A.J., McCulloch, E.A. and Till, J.E. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197, 452-454 (1963).
12. Till, J.E. and McCulloch, E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222 (1961).
13. Abramson, S., Miller, R.G. and Phillips, R.A. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J. Exp. Med. 145, 1567-1579 (1977).
14. Andrews, R.G., Singer, J.W. and Bernstein, I.D. Monoclonal antibody 12.8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67, 842-845 (1986).
15. Bruno, B., Nash, R.A., Wallace, P.M., Gass, M.J., Thompson, J., Storb, R. and McSweeney, P.A. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation. Transplantation 68, 338-344 (1999).
16. Bensinger, W.I., Buckner, C.D., Shannon-Dorcy, K., Rowley, S., Appelbaum, F.R., Benyunes, M., Clift, R., Martin, P., Demirer, T., Storb, R., Lee, M. and Schiller, G. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88, 4132-4138 (1996).
17. Barnes, D.W.H., Corp, M.J., Loutit, J.F. and Neal, F.E. Treatment of murine leukaemia with X-rays and homologous bone marrow. Preliminary communication. Br. Med. J. 2, 626-627 (1956).
18. Thomas, E.D., Lochte, H.L., Jr., Lu, W.C. and Ferrebee, J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257, 491-496 (1957).
19. Thomas, E.D., Lochte, H.L., Jr., Cannon, J.H., Sahler, O.D. and Ferrebee, J.W. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 38, 1709-1716 (1959).
20. McGovern, J.J., Jr., Russel, P.S., Atkins, L. and Webster, E.W. Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. N. Engl. J. Med. 260, 675-683 (1959).
21. Mathé, G., Amiel, J.L., Schwarzenberg, L., Cattan, A. and Schneider, M. Haematopoietic chimera in man after allogeneic (homologous) bone-marrow transplantation. Br. Med. J. 5373, 1633-1635 (1963).
22. Bortin, M.M. A compendium of reported human bone marrow transplants. Transplantation 9, 571-587 (1970).
23. Dausset, J. Iso-leuco-anticorps. Acta Haematol. 20, 156-166 (1958).
24. van Rood, J.J., Eernisse, J.G. and van Leeuwen, A. Leukocyte antibodies in sera from pregnant women. Nature 181, 1735-1736 (1958).
25. Epstein, R.B., Storb, R., Ragde, H. and Thomas, E.D. Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 6, 45-58 (1968).
26. Storb, R., Rudolph, R.H. and Thomas, E.D. Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture. J. Clin. Invest. 50, 1272-1275 (1971).
27. Storb, R., Epstein, R.B., Graham, T.C. and Thomas, E.D. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9, 240-246 (1970).
28. Storb, R. and Thomas, E.D. Graft-versus-host disease in dog and man: the Seattle experience (Review). Immunol. Rev. 88, 215-238 (1985).
29. Storb, R., Kolb, H.J., Graham, T.C., Kolb, H., Weiden, P.L. and Thomas, E.D. Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone. Blood 42, 601-609 (1973).
30. Storb, R., Rudolph, R.H., Graham, T.C. and Thomas, E.D. The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings. J. Immunol. 107, 409-413 (1971).
31. Storb, R., Floersheim, G.L., Weiden, P.L., Graham, T.C., Kolb, H.-J., Lerner, K.G., Schroeder, M.-L. and Thomas, E.D. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J. Immunol. 112, 1508-1516 (1974).
32. Weiden, P.L., Storb, R., Tsoi, M.-S., Graham, T.C., Lerner, K.G. and Thomas, E.D. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. J. Immunol. 116, 1212-1219 (1976).
33. Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R. and Good, R.A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2, 1366-1369 (1968).
34. Bach, F.H., Albertini, R.J., Joo, P., Anderson, J.L. and Bortin, M.M. Bonemarrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2, 1364-1366 (1968).
35. deKoning, J., van Bekkum, D.W., Dicke, K.A., Dooren, L.J., Radl, J. and van Rood, J.J. Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency. Lancet 1, 1223-1227 (1969).
36. Thomas, E.D., Buckner, C.D., Storb, R., Neiman, P.E., Fefer, A., Clift, R.A., Slichter, S.J., Funk, D.D., Bryant, J.I. and Lerner, K.G. Aplastic anaemia treated by marrow transplantation. Lancet 1, 284-289 (1972).
37. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Johnson, F.L., Fefer, A., Glucksberg, H., Giblett, E.R., Lerner, K.G. and Neiman, P. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43, 157-180 (1974).
38. Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. and Thomas, E.D. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68, 119-125 (1986).
39. Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V., Hansen, J., Hill, R., Lum, L., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Yee, G. and Thomas, E.D. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 314, 729-735 (1986).
40. Sorror, M.L., Leisenring, W., Deeg, H.J., Martin, P.J. and Storb, R. Twentyyear follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease (Letter to the Editor). Biol. Blood Marrow Transplant. 11, 567-568 (2005).
41. Sorror, M.L., Leisenring, W., Deeg, H.J., Martin, P.J. and Storb, R. Twentyyear follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia (Letter to the Editor). Biol. Blood Marrow Transplant. 11, 814-815 (2005).
42. Kahl, C., Leisenring, W., Deeg, H.J., Chauncey, T.R., Flowers, M.E.D., Martin, P.J., Sanders, J.E. and Storb, R. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br. J. Haematol. 130, 747-751 (2005).
43. Thomas, E.D., Buckner, C.D., Sanders, J.E., Papayannopoulou, T., Borgna- Pignatti, C., De Stefano, P., Sullivan, K.M., Clift, R.A. and Storb, R. Marrow transplantation for thalassaemia. Lancet 2, 227-229 (1982).
44. Lucarelli, G., Galimberti, M., Polchi, P., Giardini, C., Politi, P., Baronciani, D., Angelucci, E., Manenti, F., Delfini, C., Aureli, G. and Moretto, P. Marrow transplantation in patients with advanced thalassemia. N. Engl. J. Med. 316, 1050-1055 (1987).
45. Vermylen, C., Fernandez-Robles, E., Ninone, J. and Cornu, G. Bone marrow transplantation in five children with sickle cell anaemia. Lancet 1, 1427-1428 (1988).
46. Walters, M.C., Patience, M., Leisenring, W., Eckman, J.R., Scott, J.P., Mentzer, W.C., Davies, S.C., Ohene-Frempong, K., Bernaudin, F., Matthews, D.C., Storb, R. and Sullivan, K.M. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335, 369-376 (1996).
47. Johnson, F.L., Look, A.T., Gockerman, J., Ruggiero, M.R., Dalla-Pozza, L. and Billings, F.T., III. Bone-marrow transplantation in a patient with sicklecell anemia. N. Engl. J. Med. 311, 780-783 (1984).
48. Santos, G.W., Sensenbrenner, L.L., Burke, P.J., Mullins, G.M., Blas, W.B., Tutschka, P.J. and Slavin, R.E. The use of cyclophosphamide for clinical marrow transplantation. Transplant. Proc. 4, 559-564 (1972).
49. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. and Buckner, C.D. Bone-marrow transplantation. N. Engl. J. Med. 292, 832-843, 895-902 (1975).
50. Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellits, D., Sensenbrenner, L.L., Stuart, R.K. and Yeager, A.M. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N. Engl. J. Med. 309, 1347-1353 (1983).
51. Thomas, E.D., Buckner, C.D., Banaji, M., Clift, R.A., Fefer, A., Flournoy, N., Goodell, B.W., Hickman, R.O., Lerner, K.G., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J., Stevens, M., Storb, R. and Weiden, P.L. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49, 511-533 (1977).
52. Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J.W., Shulman, H., Storb, R. and Weiden, P.L. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N. Engl. J. Med. 301, 597-599 (1979).
53. Thomas, E.D., Sanders, J.E., Flournoy, N., Johnson, F.L., Buckner, C.D., Clift, R.A., Fefer, A., Goodell, B.W., Storb, R. and Weiden, P.L. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54, 468-476 (1979).
54. Thomas, E.D., Clift, R.A., Fefer, A., Appelbaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P.L. and Witherspoon, R. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Int. Med. 104, 155-163 (1986).
55. Goldman, J.M., Apperley, J.F., Jones, L., Marcus, R., Goolden, A.W.G., Batchelor, R., Hale, G., Waldmann, H., Reid, C.D., Hows, J., Gordon-Smith, E., Catovsky, D. and Galton, D.A.G. Bone marrow transplantation for patients with chronic myeloid leukemia. N. Engl. J. Med. 314, 202-207 (1986).
56. Deeg, H.J., Sullivan, K.M., Buckner, C.D., Storb, R., Appelbaum, F.R., Clift, R.A., Doney, K., Sanders, J.E., Witherspoon, R.P. and Thomas, E.D. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant. 1, 151-157 (1986).
57. Radich, J.P., Gooley, T., Bensinger, W., Chauncey, T., Clift, R., Flowers, M., Martin, P., Slattery, J., Sultan, D. and Appelbaum, F.R. HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen. Blood 102, 31-35 (2003).
58. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood 107, 2184-2191 (2006).
59. Barnes, D.W.H. and Loutit, J.F. Treatment of murine leukaemia with X-rays and homologous bone marrow: II. Br. J. Haematol. 3, 241-252 (1957).
60. Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D. and Storb, R. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300, 1068-1073 (1979).
61. Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D. and the Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus- host disease. Contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med. 304, 1529-1533 (1981).
62. Martin, P.J., Hansen, J.A., Torok-Storb, B., Durnam, D., Przepiorka, D., O’Quigley, J., Sanders, J., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Appelbaum, F.R., Stewart, P., Weiden, P., Doney, K., Buckner, C.D., Clift, R., Storb, R. and Thomas, E.D. Graft failure in patients receiving T celldepleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant. 3, 445-456 (1988).
63. Maraninchi, D., Gluckman, E., Blaise, D., Guyotat, D., Rio, B., Pico, J.L., Leblond, V., Michallet, M., Dreyfus, F., Ifrah, N. and Bordigoni, A. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet 2, 175-178 (1987).
64. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M., McGlave, P.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. and Bortin, M.M. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with Tcell depletion. Ann. Int. Med. 108, 806-814 (1988).
65. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.-J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. and Bortin, M.M. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562 (1990).
66. Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., van Rhee, F., Mittermueller, J., de Witte, T., Holler, E. and Ansari, H. Graftversus- leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86, 2041-2050 (1995).
67. Collins, R.H., Jr., Shpilberg, O., Drobyski, W.R., Porter, D.L., Giralt, S., Champlin, R., Goodman, S.A., Wolff, S.N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J.H. and Nemunaitis, J. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15, 433-444 (1997).
68. Kolb, H.J., Schmidt, C., Barrett, A.J. and Schendel, D.J. Graft-versusleukemia reactions in allogeneic chimeras. Blood 103, 767-776 (2004).
69. Speck, B., Zwaan, F.E., van Rood, J.J. and Eernisse, J.G. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HLA-A-identical unrelated donor. Transplantation 16, 24-28 (1973).
70. Hansen, J.A. and Petersdorf, E.W. Unrelated donor hematopoietic cell transplantation. In: Thomas, E.D., Blume, K.G. and Forman, S.J. (eds.), Hematopoietic Cell Transplantation (Blackwell Science, Boston, 1999), pp. 915-928.
71. Mielcarek, M., Storer, B., Kahl, C., Sandmaier, B.M., Maloney, D., Maris, M.B. and Storb, R. Nonmyeloablative and myeloablative hematopoietic cell transplantation for hematologic malignancies: outcomes with HLA-matched unrelated donors compared to HLA-identical sibling donors. Blood 106(Part 1), 194a (2005) (#658 Abstract).
72. Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., Reisner, Y. and Martelli, M.F. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N. Engl. J. Med. 339, 1186-1193 (1998).
73. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W.D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M.F. and Velardi, A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002).
74. Perruccio, K., Tosti, A., Burchielli, E., Topini, F., Ruggeri, L., Carotti, A., Capanni, M., Urbani, E., Mancusi, A., Aversa, F., Martelli, M.F., Romani, L. and Velardi, A. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 106, 4397-4406 (2005).
75. Storb, R., Epstein, R.B. and Thomas, E.D. Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. Blood 32, 662-667 (1968).
76. Burroughs, L., Mielcarek, M., Little, M.-T., Bridger, G., MacFarland, R., Fricker, S., LaBrecque, J., Sandmaier, B.M. and Storb, R. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model. Blood 106, 4002-4008 (2005).
77. Bensinger, W.I., Martin, P.J., Storer, B., Clift, R., Forman, S.J., Negrin, R., Kashyap, A., Flowers, M.E.D., Lilleby, K., Chauncey, T.R., Storb, R. and Appelbaum, F.R. Transplantation of bone marrow as compared with peripheral- blood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med. 344, 175-181 (2001).
78. Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stemcell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J. Clin. Oncol. 23, 5074-5087 (2005).
79. Gluckman, E., Broxmeyer, H.E., Auerbach, A.D., Friedman, H.S., Douglas, G.W., Devergie, A., Esperou, H., Thierry, D., Socié, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J. and Boyse, E.A. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178 (1989).
80. Gluckman, E. and Rocha, V. Donor selection for unrelated cord blood transplants (Review). Curr. Opin. Immunol. 18, 565-570 (2006).
81. Barker, J.N., Weisdorf, D.J. and Wagner, J.E. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N. Engl. J. Med. 344, 1870-1871 (2001).
82. Barker, J.N., Weisdorf, D.J., Defor, T.E., Blazar, B.R., McGlave, P.B., Miller, J.S., Verfaillie, C.M. and Wagner, J.E. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105, 1343-1347 (2005).
83. Ohishi, K., Varnum-Finney, B., Serda, R.E., Anasetti, C. and Bernstein, I.D. The notch ligand, delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 98, 1402-1407 (2001).
84. Storb, R., Yu, C., Wagner, J.L., Deeg, H.J., Nash, R.A., Kiem, H.-P., Leisenring, W. and Shulman, H. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89, 3048-3054 (1997).
85. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E.D., Georges, G.E., Grumet, F.C., Kiem, H.-P., Torok-Storb, B., Yu, C., Blume, K.G. and Storb, R.F. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97, 3390-3400 (2001).
86. Maris, M.B., Niederwieser, D., Sandmaier, B.M., Storer, B., Stuart, M., Maloney, D., Petersdorf, E., McSweeney, P., Pulsipher, M., Woolfrey, A., Chauncey, T., Agura, E., Heimfeld, S., Slattery, J., Hegenbart, U., Anasetti, C., Blume, K. and Storb, R. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 102, 2021-2030 (2003).
87. Baron, F., Sandmaier, B.M., Storer, B.E., Maris, M.B., Langston, A.A., Lange, T., Petersdorf, E., Bethge, W., Maziarz, R.T., McSweeney, P.A., Pulsipher, M.A., Wade, J.C., Chauncey, T.R., Shizuru, J.A., Sorror, M.L., Woolfrey, A.E., Maloney, D.G. and Storb, R. Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning. Biol. Blood Marrow Transplant. 13, 1041-1048 (2007).
88. Baron, F., Baker, J.E., Storb, R., Gooley, T.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Heimfeld, S., Oparin, D., Zellmer, E., Radich, J.P., Grumet, F.C., Blume, K.G., Chauncey, T.R. and Little, M.-T. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104, 2254-2262 (2004).
89. Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E.D., Mielcarek, M., Maloney, D.G. and Storb, R. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J. Clin. Oncol. 23, 1993-2003 (2005).
90. Kahl, C., Storer, B.E., Sandmaier, B.M., Mielcarek, M., Maris, M.B., Blume, K.G., Niederwieser, D., Chauncey, T.R., Forman, S.J., Agura, E., Leis, J.F., Bruno, B., Langston, A., Pulsipher, M.A., McSweeney, P.A., Wade, J.C., Epner, E., Petersen, F.B., Bethge, W.A., Maloney, D.G. and Storb, R. Relapse risk among patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 110, 2744-2748 (2007).
91. Sorror, M.L., Maris, M.B., Storer, B., Sandmaier, B.M., Diaconescu, R., Flowers, C., Maloney, D.G. and Storb, R. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplant comorbidities. Blood 104, 961-968 (2004).
92. Gopal, A.K., Pagel, J.M., Rajendran, J.G., Maloney, D.G., Appelbaum, F.R., Sorror, M.L., Sandmaier, B.M., Storb, R. and Press, O.W. Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radiotherapy. Biol. Blood Marrow Transplant. 12, 697-702 (2006).
93. 131Ianti- CD45 antibody plus fludarabine, low-dose total body irradiation and peripheral blood stem cell infusion for elderly patients with advanced acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). Blood 106(Part 1), 119a (2005) (#397 Abstract).
94. Ferrari, G., Cusella-De, A.G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. and Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530 (1998).
95. Petersen, B.E., Bowen, W.C., Patrene, K.D., Mars, W.M., Sullivan, A.K., Murase, N., Boggs, S.S., Greenberger, J.S. and Goff, J.P. Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170 (1999).
96. Gussoni, E., Soneoka, Y., Strickland, C.D., Buzney, E.A., Khan, M.K., Flint, A.F., Kunkel, L.M. and Mulligan, R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390-394 (1999).
97. Mezey, E., Chandross, K.J., Harta, G., Maki, R.A. and McKercher, S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 779-1782 (2000).
98. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A. and Anversa, P. Bone marrow cells regenerate infarcted myocardium (Letter). Nature 410, 701-705 (2001).
99. Wagers, A.J., Sherwood, R.I., Christensen, J.L. and Weissman, I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259 (2002).
100. Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D.M., Nakano, Y., Meyer, E.M., Morel, L., Petersen, B.E. and Scott, E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
101. Meignin, V., Soulier, J., Brau, F., Lemann, M., Gluckman, E., Janin, A. and Socie, G. Little evidence of donor-derived epithelial cells in early digestive acute graft-versus-host disease. Blood 103, 360-362 (2004).
102. Dell’Agnola, C., Wang, Z., Storb, R., Tapscott, S.J., Kuhr, C.S., Hauschka, S.D., Lee, R.S., Sale, G.E., Zellmer, E., Gisburne, S., Bogan, J., Kornegay, J.N., Cooper, B.J., Gooley, T.A. and Little, M.-T. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104, 4311-4318 (2004).
103. Kuhr, C.S., Lupu, M. and Storb, R. Hematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibers. Biol. Blood Marrow Transplant. 13, 886-888 (2007).
104. Sampaolesi, M., Blot, S., D’Antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J.L., Galvez, B.G., Barthelemy, I., Perani, L., Mantero, S., Guttinger, M., Pansarasa, O., Rinaldi, C., Cusella De Angelis, M.G., Torrente, Y., Bordignon, C., Bottinelli, R. and Cossu, G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579 (2006).
105. Friedenstein, A.J., Petrakova, K.V., Kurolesova, A.I. and Frolova, G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247 (1968).
106. Roecklein, B.A. and Torok-Storb, B. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 85, 997-1005 (1995).
107. Maitra, B., Szekely, E., Gjini, K., Laughlin, M.J., Dennis, J., Haynesworth, S.E. and Koc, O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33, 597-604 (2004).
108. Simmons, P.J., Przepiorka, D., Thomas, E.D. and Torok-Storb, B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328, 429-432 (1987).
109. Awaya, N., Rupert, K., Bryant, E. and Torok-Storb, B. Failure of adult marrow- derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp. Hematol. 30, 937-942 (2002).
110. Ringden, O. and Le Blanc, K. Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells. Biol. Blood Marrow Transplant. 12, 693-694 (2006).
111. Spaggiari, G.M., Capobianco, A., Becchetti, S., Mingari, M.C. and Moretta, L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL- 2-induced NK-cell proliferation. Blood 107, 1484-1490 (2006).
112. Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A. and Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48 (2002).
113. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., Mancardi, G. and Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755-1761 (2005).
114. Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I. and Lazarus, H.M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving highdose chemotherapy. J. Clin. Oncol. 18, 307-316 (2000).
115. Lazarus, H.M., Koc, O.N., Devine, S.M., Curtin, P., Maziarz, R.T., Holland, H.K., Shpall, E.J., McCarthy, P., Atkinson, K., Cooper, B.W., Gerson, S.L., Laughlin, M.J., Loberiza, F.R., Jr., Moseley, A.B. and Bacigalupo, A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11, 389-398 (2005).
116. Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. and Fibbe, W.E. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110, 2764-2767 (2007).
117. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M. and Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441 (2004).
118. Le Blanc, K., Frassoni, F., Ball, L., Lanino, E., Sundberg, B., Lonnquist, B., Roelofs, H., Dini, G., Bacigalupo, A., Locatelli, F., Fibbi, G. and Ringden, O. Mesenchymal stem cells for treatment of severe acute graft-versus-host disease. Blood 108, 226a (2006) (#753 Abstract).
119. Rao M. Meeting report: adult mesenchymal stem cells in regenerative medicine conference, August 2007. Stem Cells 25, 2973-2974 (2007).
120. Evans, M.J. and Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
121. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A. and Hearn, J.P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92, 7844-7848 (1995).
122. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. and Jones, J.M. Embryonic stem cell lines derived from human blastocysts [Erratum appears in Science 282(5395), 1827 (1998)]. Science 282 (5391), 1145-1147 (1998).
123. Shamblott, M.J., Axelman, J., Wang, S., Bugg, E.M., Littlefield, J.W., Donovan, P.J., Blumenthal, P.D., Huggins, G.R. and Gearhart, J.D. Derivation of pluripotent stem cells from cultured human primordial germ cells [Erratum appears in Proc. Natl. Acad. Sci. USA 96(3), 1162 (1999)]. Proc. Natl. Acad. Sci. USA 95, 13726-13731 (1998).
124. Storb, R., Yu, C., Zaucha, J.M., Deeg, H.J., Georges, G., Kiem, H.-P., Nash, R.A., McSweeney, P.A. and Wagner, J.L. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94, 2523-2529 (1999).
125. Jochum, C., Beste, M., Zellmer, E., Graves, S.S. and Storb, R. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation. Biol. Blood Marrow Transplant. 13, 164-171 (2007).
126. Bleakley, M. and Riddell, S.R. Molecules and mechanisms of the graft-versus- leukaemia effect. Nat. Rev. Cancer 4, 371-380 (2004).
127. Hogan, W.J., Sorror, M.L., Diaconescu, R., Zellmer, E., Little, M.-T. and Storb, R. Marrow engraftment after nonmyeloablative conditioning followed by postgrafting immunosuppression with mycophenolate mofetil, sirolimus and cyclosporine in a canine model. Blood 102(Part 2), 396b (2003) (#5311 Abstract).
128. + regulatory T cells (Treg) block alloreactive host antidonor T cells in canine mixed hematopoietic chimeras. Blood 106(Part 1), 867a (2005) (#3101 Abstract).
129. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., Kalantzi, M., Herbots, L., Sinnaeve, P., Dens, J., Maertens, J., Rademakers, F., Dymarkowski, S., Gheysens, O., Van Cleemput, J., Bormans, G., Nuyts, J., Belmans, A., Mortelmans, L., Boogaerts, M. and Van de Werf, F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121 (2006).
130. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J.G., Smith, H.J., Taraldsrud, E., Grogaard, H.K., Bjornerheim, R., Brekke, M., Muller, C., Hopp, E., Ragnarsson, A., Brinchmann, J.E. and Forfang, K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199-1209 (2006).
131. Guzman, R., Uchida, N., Bliss, T.M., He, D., Christopherson, K.K., Stellwagen, D., Capela, A., Greve, J., Malenka, R.C., Moseley, M.E., Palmer, T.D. and Steinberg, G.K. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl. Acad. Sci. USA 104, 10211-10216 (2007).
132. Wilmut, I., Beaujean, N., de Sousa, P.A., Dinnyes, A., King, T.J., Paterson, L.A., Wells, D.N. and Young, L.E. Somatic cell nuclear transfer. Nature 419, 583-586 (2002).
133. Uphoff, D.E. Genetic factors influencing irradiation protection by bone marrow. I. The F1 hybrid effect. J. Natl. Cancer Inst. 19, 123-125 (1957).
134. Thomas, E.D., Collins, J.A., Herman, E.C., Jr. and Ferrebee, J.W. Marrow transplants in lethally irradiated dogs given methotrexate. Blood 19, 217-228 (1962).
135. Mathe, G., Amiel, J.L., Schwarzenberg, L., Cattan, A. and Schneider, M. Adoptive immunotherapy of acute leukemia: experimental and clinical results. Cancer Res. 25, 1525-1531 (1965).
136. Epstein, R.B., Graham, T.C., Buckner, C.D., Bryant, J. and Thomas, E.D. Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. Blood 28, 692-707 (1966).
137. Storb, R., Epstein, R.B., Ragde, H. and Thomas, E.D. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 30, 805-811 (1967).
138. Thomas, E.D., Buckner, C.D., Rudolph, R.H., Fefer, A., Storb, R., Neiman, P.E., Bryant, J.I., Chard, R.L., Clift, R.A., Epstein, R.B., Fialkow, P.J., Funk, D.D., Giblett, E.R., Lerner, K.G., Reynolds, F.A. and Slichter, S. Allogeneic marrow grafting for hematologic malignancy using HL-A matched donorrecipient sibling pairs. Blood 38, 267-287 (1971).
139. Storb, R., Thomas, E.D., Buckner, C., Clift, R.A., Fefer, A., Glucksberg, H. and Neiman, P.E. Transplantation of bone marrow in refractory marrow failure and neoplastic diseases. Am. J. Clin. Pathol. 62, 212-217 (1974).
140. Storb, R., Gluckman, E., Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Glucksberg, H., Graham, T.C., Johnson, F.L., Lerner, K.G., Neiman, P.E. and Ochs, H. Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood 44, 57-75 (1974).
141. Clift, R.A., Buckner, C.D., Thomas, E.D., Doney, K., Fefer, A., Neiman, P.E., Singer, J., Sanders, J., Stewart, P., Sullivan, K.M., Deeg, J. and Storb, R. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet 2, 621-623 (1982).
142. Goldman, J.M., Baughan, A.S.J., McCarthy, D.M., Worsley, A.M., Hows, J.M., Gordon-Smith, E.C., Catovsky, D., Batchelor, J.R., Goolden, A.W.G. and Galton, D.A.G. Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet 2, 623-625 (1982).
143. Prentice, H.G., Blacklock, H.A., Janossy, G., Gilmore, M.J., Price-Jones, L., Tidman, N., Trejdosiewicz, L.K., Skeggs, D.B.L., Panjwani, D., Ball, S., Graphakos, S., Patterson, J., Ivory, K. and Hoffbrand, A.V. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1, 472-476 (1984).
144. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A.C., Pileri, A. and Bonadonna, G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2, 580-585 (1989).
145. Kolb, H.J., Mittermüller, J., Clemm, Ch., Holler, G., Ledderose, G., Brehm, G., Heim, M. and Wilmanns, W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76, 2462-2465 (1990).
146. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., Rowley, S., Demirer. T., Sanders, J., Storb, R. and Buckner, C.D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85, 1655-1658 (1995).
147. Korbling, M., Huh, Y.O., Durett, A., Mirza, N., Miller, P., Engel, H., Anderlini, P., van Besien, K., Andreeff, M., Przepiorka, D. and Champlin, R.E. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86, 2842-2848 (1995).
148. Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E.B., Haferlach, T., Löffler, H., Hunter, A. and Russell, N.H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85, 1666-1672 (1995).
149. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P. and Hearn, J.P. Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod. 55, 254-259 (1996).
150. Campbell, K.H., McWhir, J., Ritchie, W.A. and Wilmut, I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66 (1996).
151. Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O’Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Körbling, M., Keating, M., Kantarjian, H. and Champlin, R. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89, 4531-4536 (1997).
152. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. and Or, R. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91, 756-763 (1998).